Uddin, D. (2016) “Chemotherapy in combination with Trastuzumab is better than chemotherapy alone in HER2 positive breast cancer patients”, Barind Medical College Journal, 2(2), pp. 15–20. doi:10.70818/bmcj.2016.v02.i1.063.